Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-06-041880
Filing Date
2006-07-13
Accepted
2006-07-13 15:45:02
Documents
1
Period of Report
2006-07-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 -7-12-06 rrd124370.html 4  
1 FORM 4 -7-12-06 rrd124370.xml 4 3980
  Complete submission text file 0001181431-06-041880.txt   5848
Mailing Address 155 FEDERAL STREET BOSTON MA 02110
Business Address 155 FEDERAL STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 338 N ST MEDFIELD MA 02052
Business Address
ROBLE DANIEL T (Reporting) CIK: 0001252297 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23776 | Film No.: 06960653